GNI Group Ltd.

TSE:2160.T

3,025 (JPY) • At close November 1, 2024
Bedrijfsnaam GNI Group Ltd.
Symbool 2160.T
Munteenheid JPY
Prijs 3,025
Beurswaarde 151,439,588,850
Dividendpercentage 0%
52-weken bereik 1,537 - 3,865
Industrie Biotechnology
Sector Healthcare
CEO Dr. Ying Luo Ph.D.
Website https://www.gnipharma.com

An error occurred while fetching data.

Over GNI Group Ltd.

GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines in Japan and internationally. It provides Etuary for the treatment of idiopathic pulmonary fibrosis. The company is also developing Etuary, which is in Phase III clinical trial for the treatment of connective

Vergelijkbare Aandelen

SanBio Company Limited logo

SanBio Company Limited

4592.T

1,013 JPY

AnGes, Inc. logo

AnGes, Inc.

4563.T

49 JPY

CellSource Co., Ltd. logo

CellSource Co., Ltd.

4880.T

1,188 JPY

Eiken Chemical Co., Ltd. logo

Eiken Chemical Co., Ltd.

4549.T

2,322 JPY

Pharma Foods International Co., Ltd. logo

Pharma Foods International Co., Ltd.

2929.T

957 JPY

Elan Corporation logo

Elan Corporation

6099.T

862 JPY

Genky DrugStores Co., Ltd. logo

Genky DrugStores Co., Ltd.

9267.T

3,035 JPY

CYBERDYNE Inc. logo

CYBERDYNE Inc.

7779.T

187 JPY

MedPeer,Inc. logo

MedPeer,Inc.

6095.T

565 JPY

Cawachi Limited logo

Cawachi Limited

2664.T

2,506 JPY

Financiële Gegevens

Cijfers zijn in miljoenen (JPY)

Cijfers zijn in miljoenen (JPY)